Logout
 CME Information
 Editorial Board
 Lessons by Volume
   Volume 22
   Volume 21
   Volume 20
   Volume 19
   Volume 18
   Volume 17
   Volume 16
   Volume 15
 
 

Near-Fatal Asthma

By Mark D. Siegel, MD, FCCP

Print This | TOC | Previous | Next


References

  1. Petty TL. Treat status asthmaticus three days before it occurs. J Intensive Care Med 1989; 4:135
  2. Nannini LJ. Morbidity and mortality from acute asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; 11–27
  3. Smith DH, Weiss K, Sullivan SD. Epidemiology and costs of acute asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; 1–10
  4. Afessa B, Morales I, Cury JD. Clinical course and outcome of patients admitted to an ICU for status asthmaticus. Chest 2001; 120:1616–1621
  5. Corbridge T, Hall JB. Status asthmaticus. In: Hall JB, Schmidt GA, Wood LDH. et al. Principles of critical care. New York, NY: McGraw-Hill, 1998; 579–594
  6. McFadden E. Fatal and near-fatal asthma. N Engl J Med 1991; 324:409–411
  7. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326:501–506
  8. Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994; 149:604–610
  9. Rome LA, Lippmann ML, Dalsey WC, et al. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000; 117:1324–1329
  10. Turner MO, Noertjojo K, Vedal S, et al. Risk factors for near-fatal asthma: a case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998; 157:1804–1809
  11. Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994; 330:1329–1334
  12. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343:332–336
  13. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922; 30:689–760
  14. Aikawa T, Shimura S, Sasaki H, et al. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992; 101:916–921
  15. Nayar R, Yeldandi AV. Pathology of acute asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; 49–55
  16. Frigas E, Loegering DA, Solley GO, et al. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981; 56:345–353
  17. Synek M, Beasley R, Frew AJ, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996; 154:224–230
  18. Lamblin C, Gosset P, Tillie-Leblond I, et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998; 157:394–402
  19. Ordonez CL, Shaughnessy TE, Matthay MA, et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000; 161:1185–1190
  20. Lemjabbar H, Gosset P, Lamblin C, et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999; 159:1298–1307
  21. Kaminsky DA, Mitchell J, Carroll N, et al. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol 1999; 104:747–754
  22. Tillie-Leblond I, Hammad H, Desurmont S, et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus: potential implication in eosinophil recruitment. Am J Respir Crit Care Med 2000; 162:586–592
  23. Tillie-Leblond I, Pugin J, Marquette CH, et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159:487–494
  24. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148:713–719
  25. Molfino NA, Nannini LJ, Martelli AN, et al. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324:285–288
  26. McFadden ER Jr, Lyons HA. Arterial-blood gas tension in asthma. N Engl J Med 1968; 278:1027–1032
  27. Mountain RD, Sahn SA. Clinical features and outcome in patients with acute asthma presenting with hypercapnia. Am Rev Respir Dis 1988; 138:535–539
  28. Molfino NA. Near-fatal asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; 29–47
  29. McFadden ER. Clinical physiologic correlates in asthma. J Allergy Clin Immunol 1986; 77:1–5
  30. Picado C, Castillo JA, Montserrat JM, et al. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989; 2:127–129
  31. Rodrigo GJ, Rodrigo C. Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment. Chest 2000; 118:1547–1552
  32. Hartert TV, Wheeler AP, Sheller JR. Use of pulse oximetry to recognize severity of airflow obstruction in obstructive airway disease: correlation with pulsus paradoxus. Chest 1999; 115:475–481
  33. Manthous CA. Lactic acidosis in status asthmaticus: three cases and a review of the literature. Chest 2001; 119:1599–1602
  34. White CS, Cole RP, Lubetsky HW, et al. Acute asthma: admission chest radiography in hospitalized adult patients. Chest 1992; 100:14–16
  35. Lemarchand P, Labrune S, Herer B, et al. Cardiorespiratory arrest following peak expiratory flow measurement during attack of asthma. Chest 1991; 100:1168–1169
  36. Irwin RS. A 55-year-old man admitted to the medical ICU with the diagnosis of status asthmaticus responds poorly to intensive asthma therapy. Chest 2000; 117:892–893
  37. Murray DM, Lawler PG. All that wheezes is not asthma: paradoxical vocal cord movement presenting as severe acute asthma requiring ventilatory support. Anaesthesia 1998; 53:1006–1011
  38. Manthous CA, Hall JB, Schmidt GA, et al. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am Rev Respir Dis 1993; 148:1567–1570
  39. Manthous CA, Chatila W, Schmidt GA, et al. Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients. Chest 1995; 107:210–213
  40. Murray PT, Corbridge T. Pharmacotherapy of acute asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; 139–160
  41. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999; 107:363–370
  42. McFadden ER Jr. Dosages of corticosteroids in asthma. Am Rev Respir Dis 1993; 147:1306–1310
  43. Lin RY, Pesola GR, Bakalchuk L, et al. Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: a randomized controlled study. Ann Emerg Med 1999; 33:487–494
  44. Schaeffer EM, Pohlman A, Morgan S, et al. Oxygenation in status asthmaticus improves during ventilation with helium-oxygen. Crit Care Med 1999; 27:2666–2670
  45. Kass JE, Terregino CA. The effect of heliox in acute severe asthma: a randomized controlled trial. Chest 1999; 116:296–300
  46. Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151:310–314
  47. Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98:693–698
  48. Goode ML, Fink JB, Dhand R, et al. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001; 163:109–114
  49. Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995; 107:1576–1581
  50. Sydow M, Crozier TA, Zielmann S, et al. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med 1993; 19:467–471
  51. Camargo CA Jr, Green SA, Smithline HA, et al. Rapid bronchodilator response to intravenous montelukast in acute asthma [abstract]. Acad Emerg Med 2001; 8:414
  52. Scoggin CH, Sahn SA, Petty TL. Status asthmaticus: a nine-year experience. JAMA 1977; 238:1158–1162
  53. Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129:385–387
  54. Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150:870–874
  55. Williams TJ, Tuxen DV, Scheinkestel CD, et al. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992; 146:607–615
  56. Tuxen DV, Anderson MB, Scheinkestel CD. Mechanical ventilation for severe asthma. In: Hall JB, Corbridge TC, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; 209–228
  57. Meduri GU, Cook TR, Turner RE, et al. Noninvasive positive pressure ventilation in status asthmaticus. Chest 1996; 110:767–774
  58. Tuxen DV, Lane S. The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987; 136:872–879
  59. Tobin MJ. Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med 2000; 342:1360–1361
  60. Leatherman JW, Ravenscraft SA. Low measured auto-positive end-expiratory pressure during mechanical ventilation of patients with severe asthma: hidden auto-positive end-expiratory pressure. Crit Care Med 1996; 24:541–546
  61. Shapiro JM. Intensive care of status asthmaticus. Chest 2001; 120:1439–1441
  62. Tuxen DV, Williams TJ, Scheinkestel CD, et al. Use of a measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma. Am Rev Respir Dis 1992; 146:1136–1142
  63. Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994; 150:1722–1737
  64. Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989; 140:5–9
  65. Sethi J, Siegel MD. Mechanical ventilation in chronic obstructive lung disease. Clin Chest Med 2000; 21:799–818
  66. Laghi F, Segal J, Choe WK, et al. Effect of imposed inflation time on respiratory frequency and hyperinflation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1365–1370
  67. Siegel MD, Matthay MA. Sedatives, analgesics, and paralytic agents in the intensive care unit. In: Bone RC, Dantzker DR, George RB, et al. Pulmonary and critical care medicine. St. Louis: Mosby-Year Book; 1997; R46-1–R46-16
  68. Leatherman JW, Fluegel WL, David WS, et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1686–1690
  69. Douglass JA, Tuxen DV, Horne M, et al. Myopathy in severe asthma. Am Rev Respir Dis 1992; 146:517–519
  70. Behbehani NA, Al-Mane F, D'yachkova Y, et al. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 1999; 115:1627–1631
  71. Braman SS, Kaemmerlen JT. Intensive care of status asthmaticus: a 10-year experience. JAMA 1990; 264:366–368
  72. Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146:76–81

Copyright ©2002 American College of Chest Physicians


Print This | TOC | Previous | Next